Stroke, Vol 14, 668-676, Copyright © 1983 by American Heart Association
A randomized trial of immediate versus delayed anticoagulation of patients
with cardiogenic embolic brain infarction was carried out in a
multi-centered study. Patients who were within 48 hours of onset of deficit
and who had no evidence of hemorrhage on computed tomography (CT) were
randomized to receive either immediate heparinization or no anticoagulants
for the initial 14 days following stroke. There were 63 patients with
embolic stroke identified during the study period. Eighteen patients were
not randomized because of specific exclusion criteria or delayed
identification more than 48 hours after stroke. Of 45 patients who were
randomized, 44 patients (98%) completed the initial week of the protocol:
24 were immediately heparinized at an average of 32 hours after stroke, 21
received no immediate anticoagulation. Two patients developed delayed
hemorrhagic infarction and two patients experienced early recurrent
embolism, all among the nonanticoagulated group. Of all patients with
embolic stroke who were not receiving coumadin at onset of stroke, only two
of 56 (4%) had hemorrhagic infarction on initial CT. Follow-up CT in 40 of
these patients showed late developing hemorrhagic infarction in two
additional patients (5%). All four hemorrhagic infarctions occurred in 18
non-anticoagulated patients with large infarcts. There were no major
complications associated with immediate heparinization of 24 unselected
patients with all sizes of embolic infarction. A trend toward reduction of
early recurrent embolism was apparent. These data support immediate
anticoagulation of nonhypertensive patients with embolic brain infarction
who have no evidence of hemorrhage on CT performed 24-48 hours after
stroke.
ARTICLES
Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group
This article has been cited by other articles:
 |
|
 |
|
  R. J. Wityk Bridging Anticoagulation After Cardioembolic Stroke Arch Neurol, September 1, 2008; 65(9): 1157 - 1157. [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 630S - 669S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C. Guedes and J. M. Ferro A Systematic Review of Immediate Anticoagulation for Ischemic Stroke of Presumed Cardioembolic Origin Stroke, May 1, 2008; 39(5): e81 - e82. [Full Text] [PDF]
|
|
|
|
|
|
M. Paciaroni, G. Agnelli, S. Micheli, and V. Caso Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials Stroke, February 1, 2007; 38(2): 423 - 430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D J H McCabe and R D Rakhit Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke J. Neurol. Neurosurg. Psychiatry, January 1, 2007; 78(1): 14 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Davis and G. A. Donnan Immediate Anticoagulation for Acute Stroke in Atrial Fibrillation: No, but .... Stroke, December 1, 2006; 37(12): 3056 - 3056. [Full Text] [PDF]
|
|
|
|
|
|
M. Camerlingo, P. Salvi, G. Belloni, T. Gamba, B. M. Cesana, and A. Mamoli Intravenous Heparin Started Within the First 3 Hours After Onset of Symptoms as a Treatment for Acute Nonlacunar Hemispheric Cerebral Infarctions Stroke, November 1, 2005; 36(11): 2415 - 2420. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Benatar Heparin use in acute ischaemic stroke: does evidence change practice? QJM, February 1, 2005; 98(2): 147 - 152. [Full Text] [PDF]
|
|
|
|
 |
|
 W-P. Schmidt, P. Heuschmann, D. Taeger, H. Henningsen, H-J. Buecker-Nott, and K. Berger Determinants of IV heparin treatment in patients with ischemic stroke Neurology, December 28, 2004; 63(12): 2407 - 2409. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Salem, P. D. Stein, A. Al-Ahmad, H. I. Bussey, D. Horstkotte, N. Miller, and S. G. Pauker Antithrombotic Therapy in Valvular Heart Disease--Native and Prosthetic: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 457S - 482S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Chest, September 1, 2004; 126(3_suppl): 483S - 512S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. S. Kirshner Reducing the Risk of Stroke JAMA, April 16, 2003; 289(15): 1928 - 1928. [Full Text] [PDF]
|
|
|
|
|
|
L. R. Caplan Resolved: Heparin May Be Useful in Selected Patients With Brain Ischemia Stroke, January 1, 2003; 34(1): 230 - 231. [Full Text] [PDF]
|
|
|
|
|
|
P. Sandercock Full Heparin Anticoagulation Should Not Be Used in Acute Ischemic Stroke Stroke, January 1, 2003; 34(1): 231 - 232. [Full Text] [PDF]
|
|
|
|
|
|
R. G. Hart, S. Palacio, and L. A. Pearce Atrial Fibrillation, Stroke, and Acute Antithrombotic Therapy: Analysis of Randomized Clinical Trials Stroke, November 1, 2002; 33(11): 2722 - 2727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Saxena, S. Lewis, E. Berge, P. A.G. Sandercock, and P. J. Koudstaal Risk of Early Death and Recurrent Stroke and Effect of Heparin in 3169 Patients With Acute Ischemic Stroke and Atrial Fibrillation in the International Stroke Trial Stroke, October 1, 2001; 32(10): 2333 - 2337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro Immediate Anticoagulation in Acute Focal Brain Ischemia Revisited : Gathering the Evidence Stroke, February 1, 2001; 32(2): 577 - 578. [Full Text] [PDF]
|
|
|
|
|
|
D. N. Salem, D. Hartnett Daudelin, H. J. Levine, S. G. Pauker, M. H. Eckman, and J. Riff Antithrombotic Therapy in Valvular Heart Disease Chest, January 1, 2001; 119 (2009): 207S - 219S. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Chest, January 1, 2001; 119 (2009): 300S - 320S. [Full Text] [PDF]
|
|
|
|
|
|
L. R. Caplan When Should Heparin Be Given to Patients With Atrial Fibrillation-Related Embolic Brain Infarcts? Arch Neurol, September 1, 1999; 56(9): 1059 - 1060. [Full Text] [PDF]
|
|
|
|
|
|
A. Chamorro, N. Vila, C. Ascaso, and R. Blanc Heparin in Acute Stroke With Atrial Fibrillation: Clinical Relevance of Very Early Treatment Arch Neurol, September 1, 1999; 56(9): 1098 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. Grau and W. Hacke Is There Still a Role for Intravenous Heparin in Acute Stroke?: Yes Arch Neurol, September 1, 1999; 56(9): 1159 - 1160. [Full Text] [PDF]
|
|
|
|
|
|
P. Sandercock Is There Still a Role for Intravenous Heparin in Acute Stroke?: No Arch Neurol, September 1, 1999; 56(9): 1160 - 1162. [Full Text] [PDF]
|
|
|
|
 |
|
 H. J M Barnett, M. Eliasziw, and H. E Meldrum Evidence based cardiology: Prevention of ischaemic stroke BMJ, June 5, 1999; 318(7197): 1539 - 1543. [Full Text]
|
|
|
|
|
|
The Publications Committee for the Trial of ORG 10 Low Molecular Weight Heparinoid, ORG 10172 (Danaparoid), and Outcome After Acute Ischemic Stroke: A Randomized Controlled Trial JAMA, April 22, 1998; 279(16): 1265 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Pritz Timing of Carotid Endarterectomy After Stroke Stroke, December 1, 1997; 28(12): 2563 - 2567. [Abstract] [Full Text]
|
|
|
|
|
|
A. V. Alexandrov, S. E. Black, L. E. Ehrlich, C. B. Caldwell, and J. W. Norris Predictors of Hemorrhagic Transformation Occurring Spontaneously and on Anticoagulants in Patients With Acute Ischemic Stroke Stroke, June 1, 1997; 28(6): 1198 - 1202. [Abstract] [Full Text]
|
|
|
|
|
|
C. Morocutti, G. Amabile, F. Fattapposta, A. Nicolosi, S. Matteoli, M. Trappolini, G. Cataldo, G. Milanesi, M. Lavezzari, F. Pamparana, et al. Indobufen Versus Warfarin in the Secondary Prevention of Major Vascular Events in Nonrheumatic Atrial Fibrillation Stroke, May 1, 1997; 28(5): 1015 - 1021. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Dorman, C. Counsell, and P. Sandercock Antithrombotic Therapy in Acute Ischemic Stroke Arch Intern Med, December 11, 1995; 155(22): 2481 - 2481. [Abstract] [PDF]
|
|
|
|
|
|
W. J. Manning, D. I. Silverman, C. A. Waksmonski, P. Oettgen, and P. S. Douglas Prevalence of Residual Left Atrial Thrombi Among Patients With Acute Thromboembolism and Newly Recognized Atrial Fibrillation Arch Intern Med, November 13, 1995; 155(20): 2193 - 2197. [Abstract] [PDF]
|
|
|
|
 |
|
 D.B. Cines and M. Laposata Case 15-1995- A 70-year-old woman with atrial fibrillation and the rapid onset of hemorrhagic manifestations N. Engl. J. Med., May 18, 1995; 332(20): 1363 - 1370. [Full Text] [PDF]
|
|
|
|
|
|
H. J.M. Barnett, M. Eliasziw, and H. E. Meldrum Drugs and Surgery in the Prevention of Ischemic Stroke N. Engl. J. Med., January 26, 1995; 332(4): 238 - 248. [Full Text] [PDF]
|
|
|
|
|
|
M. Camerlingo, L. Casto, B. Censori, B. Ferraro, G. C. Gazzaniga, B. Cesana, and A. Mamoli Immediate Anticoagulation With Heparin for First-Ever Ischemic Stroke in the Carotid Artery Territories Observed Within 5 Hours of Onset Arch Neurol, May 1, 1994; 51(5): 462 - 467. [Abstract] [PDF]
|
|
|
|
|
|
J. Maher and V. C. Hachinski Anticoagulation for Embolic Stroke JAMA, March 10, 1993; 269(10): 1309 - 1309. [PDF]
|
|
|
|
 |
|
 M. Yasaka and T. Yamaguchi Immediate Anticoagulation for Intracardiac Thrombus in Acute Cardioembolic Stroke Angiology, November 1, 1992; 43(11): 886 - 892. [Abstract] [PDF]
|
|
|
|
 |
|
 J. F. Rothrock and R. G. Hart Antithrombotic Therapy in Cerebrovascular Disease Ann Intern Med, December 1, 1991; 115(11): 885 - 895. [Abstract] [PDF]
|
|
|
|
 |
|
 J. C Grotta Prevention and management of stroke Vascular Medicine, March 1, 1991; 2(1): 3 - 17. [PDF]
|
|
|
|
|
|
J. E. Wipf and B. A. Lipsky Atrial Fibrillation Arch Intern Med, August 1, 1990; 150(8): 1598 - 1603. [Abstract] [PDF]
|
|
|
|
|
|
S. R. Levine Acute Cerebral Ischemia in a Critical Care Unit: A Review of Diagnosis and Management Arch Intern Med, January 1, 1989; 149(1): 90 - 98. [Abstract] [PDF]
|
|
|
|
|
|
M. J. Alberts, E. W. Massey, and D. Dawson A Multicenter Study of Anticoagulation Parameters When Using Heparin and Warfarin Arch Neurol, December 1, 1987; 44(12): 1229 - 1231. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Sloan Thrombolysis and Stroke: Past and Future Arch Neurol, July 1, 1987; 44(7): 748 - 768. [Abstract] [PDF]
|
|
|
|
|
|
Cerebral Embolism Study Group Cardioembolic Stroke, Early Anticoagulation, and Brain Hemorrhage Arch Intern Med, April 1, 1987; 147(4): 636 - 640. [Abstract] [PDF]
|
|
|
|
|
|
M. Ramirez-Lassepas, R. J. Cipolle, R. J. Bjork, J. Kowitz, B. D. Snyder, J. C. Weber, and S. D. Stein Can Embolic Stroke Be Diagnosed on the Basis of Neurologic Clinical Criteria? Arch Neurol, January 1, 1987; 44(1): 87 - 89. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Tegeler and D. Sherman Analytic Review: Ischemic Cerebrovascular Disease: Diagnosis and Management J Intensive Care Med, July 1, 1986; 1(4): 184 - 196. [Abstract] [PDF]
|
|
|
|
|
|
M. Ramirez-Lassepas, M. R. Quinones, and H. H. Nino Treatment of Acute Ischemic Stroke: Open Trial With Continuous Intravenous Heparinization Arch Neurol, April 1, 1986; 43(4): 386 - 390. [Abstract] [PDF]
|
|
|
|
|
|
I. Starkey and C. Warlow The Secondary Prevention of Stroke in Patients With Atrial Fibrillation Arch Neurol, January 1, 1986; 43(1): 66 - 68. [Abstract] [PDF]
|
|
|
|
|
|
D. G. Sherman, R. G. Hart, and J. D. Easton The Secondary Prevention of Stroke in Patients With Atrial Fibrillation Arch Neurol, January 1, 1986; 43(1): 68 - 70. [Abstract] [PDF]
|
|
|
|
|
|
Cerebral Embolism Task Force Cardiogenic Brain Embolism Arch Neurol, January 1, 1986; 43(1): 71 - 84. [Abstract] [PDF]
|
|
|
|
|
|
F. N. Brand, R. D. Abbott, W. B. Kannel, and P. A. Wolf Characteristics and Prognosis of Lone Atrial Fibrillation: 30-Year Follow-up in the Framingham Study JAMA, December 27, 1985; 254(24): 3449 - 3453. [Abstract] [PDF]
|
|
|
|
|
|
R. G. Hart Early Recurrent Embolism Rheumatic Heart Disease Arch Neurol, November 1, 1985; 42(11): 1033 - 1033. [Abstract] [PDF]
|
|
|
|
|
|
L. Calandre, J. F. Ortega, S. Gomora, and F. Bermejo Anticoagulation and Bleeding Into Embolic Infarcts-Reply Arch Neurol, November 1, 1985; 42(11): 1034 - 1035. [Abstract] [PDF]
|
|
|
|
|
|
J. Bogousslavsky Anticoagulation and Bleeding Into Embolic Infarcts Arch Neurol, November 1, 1985; 42(11): 1033 - 1034. [Abstract] [PDF]
|
|
|
|
|
|
R. G. Hart Cere bral Emboli of Cardiac Origin Arch Intern Med, July 1, 1985; 145(7): 1329 - 1329. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Martin and J. Biller Cerebral Emboli of Cardiac Origin-Reply Arch Intern Med, July 1, 1985; 145(7): 1329 - 1330. [Abstract] [PDF]
|
|
|
|
|
|
G. J. Martin and J. Biller Nonseptic Cerebral Emboli of Cardiac Origin Arch Intern Med, October 1, 1984; 144(10): 1997 - 1999. [Abstract] [PDF]
|
|